Tissue Engineering in Urology

Anthony Atala

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Tissue engineering, one of the major components of regenerative medicine, follows the principles of cell transplantation, materials science, and engineering to develop biological substitutes that can restore and maintain normal organ function. Tissue engineering strategies generally fall into two categories: the use of acellular matrices designed to direct the body's natural ability to use its own cells to regenerate damaged tissue, and the use of matrices seeded with cells in the laboratory to produce novel tissues and organs. Efforts in regenerative medicine are currently underway experimentally for virtually every type of tissue and organ in the human body. As regenerative medicine incorporates the fields of tissue engineering, cell biology, nuclear transfer, and materials science, personnel who have mastered the techniques of cell harvest, culture, expansion, and transplantation, as well as polymer design, are essential for the successful application of these technologies to extend human life. Various tissues are at different stages of development, with some already being used clinically, a few in preclinical trials and some in the discovery stage. Recent progress suggests that engineered tissues may have an expanded clinical applicability in the future and may represent a viable therapeutic option for those who would benefit from the life-extending benefits of tissue replacement or repair.

Original languageEnglish
Title of host publicationRegenerative Nephrology
PublisherElsevier Inc.
Pages389-400
Number of pages12
ISBN (Print)9780123809285
DOIs
StatePublished - Dec 1 2011
Externally publishedYes

Fingerprint

Urology
Tissue Engineering
Regenerative Medicine
Cell Transplantation
Human Body
Cell Biology
Polymers
Cell Culture Techniques
Transplantation
Technology

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Atala, A. (2011). Tissue Engineering in Urology. In Regenerative Nephrology (pp. 389-400). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-380928-5.10024-7

Tissue Engineering in Urology. / Atala, Anthony.

Regenerative Nephrology. Elsevier Inc., 2011. p. 389-400.

Research output: Chapter in Book/Report/Conference proceedingChapter

Atala, A 2011, Tissue Engineering in Urology. in Regenerative Nephrology. Elsevier Inc., pp. 389-400. https://doi.org/10.1016/B978-0-12-380928-5.10024-7
Atala A. Tissue Engineering in Urology. In Regenerative Nephrology. Elsevier Inc. 2011. p. 389-400 https://doi.org/10.1016/B978-0-12-380928-5.10024-7
Atala, Anthony. / Tissue Engineering in Urology. Regenerative Nephrology. Elsevier Inc., 2011. pp. 389-400
@inbook{0813028c941141798119a0a93ad0b566,
title = "Tissue Engineering in Urology",
abstract = "Tissue engineering, one of the major components of regenerative medicine, follows the principles of cell transplantation, materials science, and engineering to develop biological substitutes that can restore and maintain normal organ function. Tissue engineering strategies generally fall into two categories: the use of acellular matrices designed to direct the body's natural ability to use its own cells to regenerate damaged tissue, and the use of matrices seeded with cells in the laboratory to produce novel tissues and organs. Efforts in regenerative medicine are currently underway experimentally for virtually every type of tissue and organ in the human body. As regenerative medicine incorporates the fields of tissue engineering, cell biology, nuclear transfer, and materials science, personnel who have mastered the techniques of cell harvest, culture, expansion, and transplantation, as well as polymer design, are essential for the successful application of these technologies to extend human life. Various tissues are at different stages of development, with some already being used clinically, a few in preclinical trials and some in the discovery stage. Recent progress suggests that engineered tissues may have an expanded clinical applicability in the future and may represent a viable therapeutic option for those who would benefit from the life-extending benefits of tissue replacement or repair.",
author = "Anthony Atala",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/B978-0-12-380928-5.10024-7",
language = "English",
isbn = "9780123809285",
pages = "389--400",
booktitle = "Regenerative Nephrology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Tissue Engineering in Urology

AU - Atala, Anthony

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Tissue engineering, one of the major components of regenerative medicine, follows the principles of cell transplantation, materials science, and engineering to develop biological substitutes that can restore and maintain normal organ function. Tissue engineering strategies generally fall into two categories: the use of acellular matrices designed to direct the body's natural ability to use its own cells to regenerate damaged tissue, and the use of matrices seeded with cells in the laboratory to produce novel tissues and organs. Efforts in regenerative medicine are currently underway experimentally for virtually every type of tissue and organ in the human body. As regenerative medicine incorporates the fields of tissue engineering, cell biology, nuclear transfer, and materials science, personnel who have mastered the techniques of cell harvest, culture, expansion, and transplantation, as well as polymer design, are essential for the successful application of these technologies to extend human life. Various tissues are at different stages of development, with some already being used clinically, a few in preclinical trials and some in the discovery stage. Recent progress suggests that engineered tissues may have an expanded clinical applicability in the future and may represent a viable therapeutic option for those who would benefit from the life-extending benefits of tissue replacement or repair.

AB - Tissue engineering, one of the major components of regenerative medicine, follows the principles of cell transplantation, materials science, and engineering to develop biological substitutes that can restore and maintain normal organ function. Tissue engineering strategies generally fall into two categories: the use of acellular matrices designed to direct the body's natural ability to use its own cells to regenerate damaged tissue, and the use of matrices seeded with cells in the laboratory to produce novel tissues and organs. Efforts in regenerative medicine are currently underway experimentally for virtually every type of tissue and organ in the human body. As regenerative medicine incorporates the fields of tissue engineering, cell biology, nuclear transfer, and materials science, personnel who have mastered the techniques of cell harvest, culture, expansion, and transplantation, as well as polymer design, are essential for the successful application of these technologies to extend human life. Various tissues are at different stages of development, with some already being used clinically, a few in preclinical trials and some in the discovery stage. Recent progress suggests that engineered tissues may have an expanded clinical applicability in the future and may represent a viable therapeutic option for those who would benefit from the life-extending benefits of tissue replacement or repair.

UR - http://www.scopus.com/inward/record.url?scp=84882474410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882474410&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-380928-5.10024-7

DO - 10.1016/B978-0-12-380928-5.10024-7

M3 - Chapter

AN - SCOPUS:84882474410

SN - 9780123809285

SP - 389

EP - 400

BT - Regenerative Nephrology

PB - Elsevier Inc.

ER -